Acutus Medical surges on launch of heart surgery product

Acutus Medical

27/06/2022 16:39

** Shares of Acutus Medical  AFIB.O  more than double to
$1.13 - set for their biggest monthly gain ever
    ** AFIB says it is commercially launching another device to
access the left side of the heart in the United States
 urn:newsml:reuters.com:*:nGNXc5nFM7
    ** Medical device maker says it received FDA clearance for
the AcQCross Qx system meant to reduce exchanges of wires and
needles while trying to cross the heart wall to access the left
side
    ** The clearance expands AFIB's portfoilio of products used
in left-heart procedures, the company says 
    ** AFIB in April entered into an agreement to sell its
left-heart access portfolio, including its AcQCross line of
catheters, to larger rival Medtronic  MDT.N ; MDT shares up 0.7%
    ** AFIB shares down 67% YTD

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com;))